An Interview With Daniel Fischer, President and CEO of Tevard Biosciences
Rare Disease Advisor senior correspondent Larry Luxner interviews Tevard Biosciences president and CEO Daniel Fischer, whose daughter has Dravet syndrome.
Rare Disease Advisor senior correspondent Larry Luxner interviews Tevard Biosciences president and CEO Daniel Fischer, whose daughter has Dravet syndrome.
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Jason Tardio, chief operating officer at drug developer Ovid Therapeutics.
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Bonni Goldstein, MD, a pediatrician and medical cannabis specialist.
Which of the statements below about the prognosis of Dravet syndrome (DS) are correct? Select one of the options for each question, then submit your answers to see how well you scored and how other test takers voted. Read more about DS prognosis.
Which of the statements below about the history of Dravet syndrome (DS) are correct? Select one of the options for each question, then submit your answers to see how well you scored and how other test takers voted. Read more about DS history.
Which of the statements below about the epidemiology of Dravet syndrome (DS) are correct? Select one of the options for each question, then submit your answers to see how well you scored and how other test takers voted. Read more about DS epidemiology.